Researchers have discovered how an oncogene gets activated in mature B cells, suggesting a new target for therapy in B cell lymphomas. The study marks the first time researchers have understood how the over-activation of c-myc can lead to blood-related cancers.
Leave a Reply
You must be logged in to post a comment.